Wells Fargo’s Nobilis Health Corp. HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-12,000
Closed -$23K 6586
2017
Q2
$23K Sell
12,000
-24,812
-67% -$37.6K ﹤0.01% 5607
2017
Q1
$63K Buy
36,812
+15,189
+70% +$31.6K ﹤0.01% 5370
2016
Q4
$46K Buy
21,623
+2,145
+11% +$5.84K ﹤0.01% 5396
2016
Q3
$65K Buy
19,478
+9,437
+94% +$28.4K ﹤0.01% 5167
2016
Q2
$22K Sell
10,041
-3,823
-28% -$12.4K ﹤0.01% 5470
2016
Q1
$44K Buy
13,864
+13,710
+8,903% +$35.5K ﹤0.01% 5265
2015
Q4
$0 Sell
154
-9
-6% -$29 ﹤0.01% 6532
2015
Q3
$1K Sell
163
-1,437
-90% -$8.25K ﹤0.01% 6116
2015
Q2
$11K Buy
+1,600
New +$11.3K ﹤0.01% 5792

Other funds holding HLTH

Wells Fargo's HLTH Position: Q3 2017 in Review

Wells Fargo sold out of Nobilis Health Corp. (HLTH) in Q3 2017, closing a stake of 12,000 shares — an estimated $23K sold.

Wells Fargo first reported a position in HLTH in Q2 2015 and held it in 9 quarters. The position peaked at $65K in Q3 2016. 40 funds tracked by Wall St. Rank hold HLTH as of Q3 2017.

  • Wells Fargo reported no remaining Nobilis Health Corp. position as of Q3 2017 after selling out during the quarter.
  • Wells Fargo sold 12,000 Nobilis Health Corp. shares in Q3 2017, an estimated $23K.
  • Wells Fargo first reported a position in Nobilis Health Corp. in Q2 2015 and held it in 9 quarters.
  • Wells Fargo's Nobilis Health Corp. position peaked at $65K in Q3 2016.
  • 40 funds tracked by Wall St. Rank held Nobilis Health Corp. as of Q3 2017.

Based on Wells Fargo's 13F filing for Q3 2017, filed 9 Nov 2017.